IMNM earnings: real EPS beat/miss history, analyst consensus Buy, P/E -9.57. Updated 2026-07-23.
Immunome (IMNM) Research Hub
Immunome (IMNM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 24.67 USD (-5.55%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.57, market cap 2.16B. This hub links to the full technical, earnings and options research available for IMNM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 24.67 USD (-5.55%) |
| 52-week range | 17.95 USD – 30.06 USD |
| Trend regime | Range |
| 14-day RSI | 48.5 (Neutral) |
| Trailing P/E | -9.57 |
| Market cap | 2.16B |
| Dividend yield | 0.00% |
Available research for IMNM
Covered Call on IMNM: how it works, illustrative setup around the real 24.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IMNM: how it works, illustrative setup around the real 24.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IMNM: how it works, illustrative setup around the real 24.67 USD price, max profit/loss, breakeven and when to use it. Educational.
IMNM technical analysis: range, last 24.67 USD, RSI 48.5, 52w range 17.95 USD–30.06 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IMNM in?
Immunome (IMNM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IMNM in an uptrend or downtrend?
As of 2026-09-11, IMNM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IMNM's trailing P/E ratio?
IMNM's trailing P/E is -9.57, with a market cap of 2.16B. See the earnings research page for full valuation detail.